TY - JOUR
T1 - Prevention and treatment of low back pain
T2 - evidence, challenges, and promising directions
AU - Foster, Nadine E.
AU - Anema, Johannes R.
AU - Cherkin, Dan
AU - Chou, Roger
AU - Cohen, Steven P.
AU - Gross, Douglas P.
AU - Ferreira, Paulo H.
AU - Fritz, Julie M.
AU - Koes, Bart W.
AU - Peul, Wilco C.
AU - Turner, Judith A.
AU - Maher, Chris G.
AU - Buchbinder, Rachelle
AU - Hartvigsen, Jan
AU - Cherkin, Dan
AU - Foster, Nadine E.
AU - Maher, Chris G.
AU - Lancet Low Back Pain Series Working Group
A2 - Underwood, Martin
A2 - van Tulder, Maurits
A2 - Anema, Johannes R.
A2 - Chou, Roger
A2 - Cohen, Stephen P.
A2 - Menezes Costa, Lucíola
A2 - Croft, Peter
A2 - Ferreira, Manuela
A2 - Ferreira, Paulo H.
A2 - Fritz, Julie M.
A2 - Genevay, Stéphane
A2 - Gross, Douglas P.
A2 - Hancock, Mark J.
A2 - Hoy, Damian
A2 - Karppinen, Jaro
A2 - Koes, Bart W.
A2 - Kongsted, Alice
A2 - Louw, Quinette
A2 - Öberg, Birgitta
A2 - Peul, Wilco C.
A2 - Pransky, Glenn
A2 - Schoene, Mark
A2 - Sieper, Joachim
A2 - Smeets, Rob J.
A2 - Turner, Judith A.
A2 - Woolf, Anthony
N1 - Copyright © 2018 Elsevier Ltd. All rights reserved.
PY - 2018/6/9
Y1 - 2018/6/9
N2 - Many clinical practice guidelines recommend similar approaches for the assessment and management of low back pain. Recommendations include use of a biopsychosocial framework to guide management with initial non-pharmacological treatment, including education that supports self-management and resumption of normal activities and exercise, and psychological programmes for those with persistent symptoms. Guidelines recommend prudent use of medication, imaging, and surgery. The recommendations are based on trials almost exclusively from high-income countries, focused mainly on treatments rather than on prevention, with limited data for cost-effectiveness. However, globally, gaps between evidence and practice exist, with limited use of recommended first-line treatments and inappropriately high use of imaging, rest, opioids, spinal injections, and surgery. Doing more of the same will not reduce back-related disability or its long-term consequences. The advances with the greatest potential are arguably those that align practice with the evidence, reduce the focus on spinal abnormalities, and ensure promotion of activity and function, including work participation. We have identified effective, promising, or emerging solutions that could offer new directions, but that need greater attention and further research to determine if they are appropriate for large-scale implementation. These potential solutions include focused strategies to implement best practice, the redesign of clinical pathways, integrated health and occupational interventions to reduce work disability, changes in compensation and disability claims policies, and public health and prevention strategies.
AB - Many clinical practice guidelines recommend similar approaches for the assessment and management of low back pain. Recommendations include use of a biopsychosocial framework to guide management with initial non-pharmacological treatment, including education that supports self-management and resumption of normal activities and exercise, and psychological programmes for those with persistent symptoms. Guidelines recommend prudent use of medication, imaging, and surgery. The recommendations are based on trials almost exclusively from high-income countries, focused mainly on treatments rather than on prevention, with limited data for cost-effectiveness. However, globally, gaps between evidence and practice exist, with limited use of recommended first-line treatments and inappropriately high use of imaging, rest, opioids, spinal injections, and surgery. Doing more of the same will not reduce back-related disability or its long-term consequences. The advances with the greatest potential are arguably those that align practice with the evidence, reduce the focus on spinal abnormalities, and ensure promotion of activity and function, including work participation. We have identified effective, promising, or emerging solutions that could offer new directions, but that need greater attention and further research to determine if they are appropriate for large-scale implementation. These potential solutions include focused strategies to implement best practice, the redesign of clinical pathways, integrated health and occupational interventions to reduce work disability, changes in compensation and disability claims policies, and public health and prevention strategies.
KW - Analgesics, Opioid/administration & dosage
KW - Chronic Pain/prevention & control
KW - Cost-Benefit Analysis/standards
KW - Diagnostic Imaging/economics
KW - Female
KW - Humans
KW - Low Back Pain/economics
KW - Male
KW - Pain Management/economics
KW - Practice Guidelines as Topic/standards
KW - United States Public Health Service/standards
KW - United States/epidemiology
U2 - 10.1016/S0140-6736(18)30489-6
DO - 10.1016/S0140-6736(18)30489-6
M3 - Journal article
C2 - 29573872
AN - SCOPUS:85044127957
SN - 0140-6736
VL - 391
SP - 2368
EP - 2383
JO - The Lancet
JF - The Lancet
IS - 10137
ER -